This is HUGE.
EmtinB demonstrated the largest ever improvement in neurite growth and increased number of active connections between nerve cells. Treatment with EmtinB produced longest axon ever sampled by this disease model. An increase in the length of axon is a measure of nerve’s cell ability to regenerate
▪ EmtinB stimulated nerve regeneration exceeding 300% compared to control and double that of Copaxon®, the leading marketed drug for Multiple Sclerosis with peak annual sales of $4 billion dollars
▪ Results clearly demonstrate significant promise of Emtins’ neuroprotective effects in multiple neurodegenerative diseases, such as Alzheimer’s, Multiple Sclerosis, Parkinson’s, etc.
Market Cap $10M with $5M+ cash
- Forums
- ASX - By Stock
- NSB
- Ann: NSB - Breakthrough results from Spinal Cord Injury Model
Ann: NSB - Breakthrough results from Spinal Cord Injury Model, page-3
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.001(2.56%) |
Mkt cap ! $5.784M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.6¢ | $5.263K | 142.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20181 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 125000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20181 | 0.036 |
3 | 428000 | 0.035 |
1 | 600000 | 0.033 |
2 | 533332 | 0.030 |
2 | 108800 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 125000 | 1 |
0.042 | 27998 | 1 |
0.046 | 25000 | 1 |
0.050 | 1086 | 1 |
0.051 | 75976 | 1 |
Last trade - 15.40pm 28/06/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online